Home LiteratureArticle Details
PMID: 15254203 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Role of CD8+ T cells in control of West Nile virus infection.

Journal of virology ·Vol. 78 ·No. 15 ·2004-08-00 ·Pages 8312-21

Shrestha B, Diamond MS

Abstract

Infection with West Nile virus (WNV) causes fatal encephalitis more frequently in immunocompromised humans than in those with a healthy immune system. Although a complete understanding of this increased risk remains unclear, experiments with mice have begun to define how different components of the adaptive and innate immune response function to limit infection. Previously, we demonstrated that components of humoral immunity, particularly immunoglobulin M (IgM) and IgG, have critical roles in preventing dissemination of WNV infection to the central nervous system. In this study, we addressed the function of CD8(+) T cells in controlling WNV infection. Mice that lacked CD8(+) T cells or classical class Ia major histocompatibility complex (MHC) antigens had higher central nervous system viral burdens and increased mortality rates after infection with a low-passage-number WNV isolate. In contrast, an absence of CD8(+) T cells had no effect on the qualitative or quantitative antibody response and did not alter the kinetics or magnitude of viremia. In the subset of CD8(+)-T-cell-deficient mice that survived initial WNV challenge, infectious virus was recovered from central nervous system compartments for several weeks. Primary or memory CD8(+) T cells that were generated in vivo efficiently killed target cells that displayed WNV antigens in a class I MHC-restricted manner. Collectively, our experiments suggest that, while specific antibody is responsible for terminating viremia, CD8(+) T cells have an important function in clearing infection from tissues and preventing viral persistence.

MeSH Terms
Animals Antibodies, Viral/blood CD8-Positive T-Lymphocytes/immunology,physiology Central Nervous System/virology Cytotoxicity, Immunologic Histocompatibility Antigens Class II/physiology Mice Mice, Inbred C57BL Spleen/virology Viral Load Viremia/etiology West Nile Fever/etiology West Nile virus/isolation & purification
Chemicals
Antibodies, Viral Histocompatibility Antigens Class II
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Shrestha Bimmi
Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA.
Diamond Michael S
References (70)
70 references, click to expand
  1. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.
    J Virol. 2003 Feb;77(4):2578-86 PMID: 12551996
  2. A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies.
    Virology. 1983 Apr 30;126(2):525-37 PMID: 6190308
  3. The utility of siRNA transcripts produced by RNA polymerase i in down regulating viral gene expression and replication of negative- and positive-strand RNA viruses.
    Virology. 2003 Sep 1;313(2):514-24 PMID: 12954218
  4. West Nile virus infection modulates the expression of class I and class II MHC antigens on astrocytes in vitro.
    Ann N Y Acad Sci. 1988;540:483-5 PMID: 2849899
  5. Study on West Nile virus persistence in monkeys.
    Arch Virol. 1983;75(1-2):71-86 PMID: 6299247
  6. Partial genetic characterization of West Nile virus strains, New York State, 2000.
    Emerg Infect Dis. 2001 Jul-Aug;7(4):650-3 PMID: 11585527
  7. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies.
    J Immunol. 1988 Nov 15;141(10):3606-10 PMID: 2460542
  8. West Nile poliomyelitis.
    Lancet Infect Dis. 2003 Jan;3(1):9-10 PMID: 12505023
  9. Persistence of tick-borne encephalitis virus in monkeys. II. Effectiveness of methods used for virus detection.
    Acta Virol. 1981 Nov;25(6):344-51 PMID: 6120635
  10. Antibody prophylaxis and therapy for flavivirus encephalitis infections.
    Ann N Y Acad Sci. 2001 Dec;951:286-97 PMID: 11797785
  11. West Nile fever--a reemerging mosquito-borne viral disease in Europe.
    Emerg Infect Dis. 1999 Sep-Oct;5(5):643-50 PMID: 10511520
  12. The West Nile Virus outbreak of 1999 in New York: the Flushing Hospital experience.
    Clin Infect Dis. 2000 Mar;30(3):413-8 PMID: 10722421
  13. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells.
    J Infect Dis. 2000 Oct;182(4):1214-7 PMID: 10979920
  14. CTL recognition of west Nile virus-infected fibroblasts is cell cycle dependent and is associated with virus-induced increases in class I MHC antigen expression.
    Immunology. 1994 Aug;82(4):561-70 PMID: 7835918
  15. A poliomyelitis-like syndrome from West Nile virus infection.
    N Engl J Med. 2002 Oct 17;347(16):1279-80 PMID: 12270971
  16. Monoclonal antibody analysis of MHC expression in human brain biopsies: tissue ranging from "histologically normal" to that showing different levels of glial tumor involvement.
    J Immunol. 1986 Jun 1;136(11):4054-62 PMID: 2422272
  17. Expression of MHC class I heavy chain and beta2-microglobulin in rat brainstem motoneurons and nigral dopaminergic neurons.
    J Neuroimmunol. 1999 Nov 1;101(1):76-86 PMID: 10580816
  18. West Nile encephalitis epidemic in southeastern Romania.
    Lancet. 1998 Sep 5;352(9130):767-71 PMID: 9737281
  19. Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons.
    Science. 2001 Jul 13;293(5528):303-6 PMID: 11452126
  20. Biochemical, cellular, and pharmacological aspects of the multidrug transporter.
    Annu Rev Pharmacol Toxicol. 1999;39:361-98 PMID: 10331089
  21. Expression of MHC class I and beta2-microglobulin in rat spinal motoneurons: regulatory influences by IFN-gamma and axotomy.
    Exp Neurol. 1998 Apr;150(2):282-95 PMID: 9527898
  22. Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses.
    Eur J Immunol. 1999 Apr;29(4):1243-52 PMID: 10229092
  23. Identification of cytolytic lymphocytes in West Nile virus-infected murine central nervous system.
    J Gen Virol. 1989 Mar;70 ( Pt 3):565-73 PMID: 2543751
  24. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.
    J Gen Virol. 1995 Jan;76 ( Pt 1):217-20 PMID: 7844536
  25. Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production.
    J Clin Invest. 1989 Feb;83(2):506-13 PMID: 2521489
  26. Experimental encephalitis following peripheral inoculation of West Nile virus in mice of different ages.
    J Hyg (Lond). 1970 Sep;68(3):435-46 PMID: 4917916
  27. West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice.
    Arch Virol. 1996;141(3-4):459-69 PMID: 8645088
  28. Pathogenesis of West Nile Virus encephalitis in mice and rats. 1. Influence of age and species on mortality and infection.
    Am J Epidemiol. 1967 Nov;86(3):765-75 PMID: 6081390
  29. West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis.
    Emerg Infect Dis. 2001 Jul-Aug;7(4):714-21 PMID: 11585537
  30. Persistence of tic-borne encephalitis virus in monkeys. III. Phenotypes of the persisting virus.
    Acta Virol. 1981 Nov;25(6):352-60 PMID: 6120636
  31. Immunosuppression: a means to assess the role of the immune response in acute virus infections.
    Fed Proc. 1971 Nov-Dec;30(6):1822-30 PMID: 5001450
  32. Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID mice.
    Arch Virol. 1994;137(3-4):355-70 PMID: 7944955
  33. Persistence of the Virus of St. Louis Encephalitis in the Central Nervous System of Mice for Over Five Months.
    J Bacteriol. 1943 Aug;46(2):113-6 PMID: 16560683
  34. Flavivirus infection up-regulates the expression of class I and class II major histocompatibility antigens on and enhances T cell recognition of astrocytes in vitro.
    J Neuroimmunol. 1989 Feb;21(2-3):157-68 PMID: 2463998
  35. CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis.
    J Virol. 2003 Dec;77(24):13323-34 PMID: 14645588
  36. Regulation of class I MHC gene expression in the developing and mature CNS by neural activity.
    Neuron. 1998 Sep;21(3):505-20 PMID: 9768838
  37. The primary in vivo murine cytotoxic T cell response to the flavivirus, West Nile.
    J Gen Virol. 1987 Jul;68 ( Pt 7):2001-6 PMID: 3496425
  38. Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay.
    J Clin Microbiol. 2000 Nov;38(11):4066-71 PMID: 11060069
  39. Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection.
    Am J Trop Med Hyg. 1989 Nov;41(5):576-80 PMID: 2817214
  40. Infection and injury of neurons by West Nile encephalitis virus.
    J Virol. 2003 Dec;77(24):13203-13 PMID: 14645577
  41. Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein.
    J Gen Virol. 1989 Aug;70 ( Pt 8):2037-49 PMID: 2549181
  42. The role of CD8(+) T cells and major histocompatibility complex class I expression in the central nervous system of mice infected with neurovirulent Sindbis virus.
    J Virol. 2000 Jul;74(13):6117-25 PMID: 10846095
  43. Persistence of tick-borne encephalitis virus in monkeys. I. Features of experimental infection.
    Acta Virol. 1981 Nov;25(6):337-43 PMID: 6120634
  44. Cytotoxic T lymphocytes in dengue virus infection.
    Curr Top Microbiol Immunol. 1994;189:93-108 PMID: 7924440
  45. Lack of both Fas ligand and perforin protects from flavivirus-mediated encephalitis in mice.
    J Virol. 2002 Apr;76(7):3202-11 PMID: 11884544
  46. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice.
    J Infect Dis. 2003 Jul 1;188(1):5-12 PMID: 12825165
  47. The secondary in vitro murine cytotoxic T cell response to the flavivirus, West Nile.
    Immunol Cell Biol. 1988 Feb;66 ( Pt 1):23-32 PMID: 3259537
  48. In vitro T-cell proliferative response to the flavivirus, west Nile.
    Viral Immunol. 1991 Summer;4(2):73-82 PMID: 1722099
  49. Pathogenesis of West Nile Virus encepahlitis in mice and rats. II. Virus multiplication, evolution of immunofluorescence, and development of histological lesions in the brain.
    Am J Epidemiol. 1967 Nov;86(3):776-90 PMID: 4866286
  50. Susceptibility of BL6 nude (congenitally athymic) mice to Japanese encephalitis virus by the peripheral route.
    Acta Virol. 1993 Aug;37(4):232-40 PMID: 7905237
  51. Definition of an epitope on Japanese encephalitis virus (JEV) envelope protein recognized by JEV-specific murine CD8+ cytotoxic T lymphocytes.
    Arch Virol. 2000;145(3):523-34 PMID: 10795519
  52. Interaction of flaviviruses with cells of the vertebrate host and decoy of the immune response.
    Immunol Cell Biol. 2003 Jun;81(3):207-16 PMID: 12752685
  53. Interferon-independent increases in class I major histocompatibility complex antigen expression follow flavivirus infection.
    J Gen Virol. 1988 Oct;69 ( Pt 10):2535-43 PMID: 2844965
  54. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
    J Immunol. 2004 Jan 1;172(1):550-9 PMID: 14688366
  55. Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice.
    J Virol. 2003 Dec;77(24):12941-9 PMID: 14645550
  56. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.
    J Immunol. 1985 Oct;135(4):2805-9 PMID: 4031501
  57. The expression of major histocompatibility complex (MHC) class I antigens in the brain differs markedly in acute and persistent infections with lymphocytic choriomeningitis virus (LCMV).
    J Neuroimmunol. 1992 Feb;36(2-3):193-8 PMID: 1732281
  58. The persistence of louping ill virus in immunosuppressed guinea-pigs.
    Br J Exp Pathol. 1971 Aug;52(4):395-407 PMID: 4936536
  59. MHC class I up-regulation by flaviviruses: Immune interaction with unknown advantage to host or pathogen.
    Immunol Cell Biol. 2003 Jun;81(3):217-23 PMID: 12752686
  60. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States.
    Science. 1999 Dec 17;286(5448):2333-7 PMID: 10600742
  61. Immune-mediated clearance of virus from the central nervous system.
    Microbes Infect. 2003 Apr;5(5):439-48 PMID: 12738000
  62. Persistence, latency and reactivation of Japanese encephalitis virus infection in mice.
    J Gen Virol. 1986 Feb;67 ( Pt 2):381-5 PMID: 3003242
  63. Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus.
    Viral Immunol. 2003;16(3):259-78 PMID: 14583143
  64. Persistence of tick-borne encephalitis virus in monkeys. VII. Some features of the immune response.
    Acta Virol. 1984 Sep;28(5):407-15 PMID: 6151355
  65. T cell activation in vivo by dengue virus infection.
    J Clin Lab Immunol. 1995;46(1):35-40 PMID: 9363590
  66. Dengue virus-specific, human CD4+ CD8- cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones.
    J Virol. 1991 Apr;65(4):1823-8 PMID: 1705990
  67. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus.
    J Gen Virol. 1988 Aug;69 ( Pt 8):2101-7 PMID: 3404125
  68. Pathogenesis of flavivirus encephalitis.
    Adv Virus Res. 2003;60:273-342 PMID: 14689697
  69. Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells.
    J Gen Virol. 1996 Apr;77 ( Pt 4):705-14 PMID: 8627259
  70. IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection.
    J Immunol. 2003 Sep 1;171(5):2524-31 PMID: 12928402
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2004-08-00
Pages
8312-21
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC446114
Subset
IM
Grants
NIAID NIH HHS · U54 AI057160 · United States
ODCDC CDC HHS · U50/CCU720545-02 · United States
NIAID NIH HHS · U54 AI057160-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com